Literature DB >> 23516324

Cognitive impairment differs between primary progressive and relapsing-remitting MS.

Aurélie Ruet1, Mathilde Deloire, Julie Charré-Morin, Delphine Hamel, Bruno Brochet.   

Abstract

OBJECTIVES: To characterize the cognitive abilities of patients with primary progressive multiple sclerosis (PPMS) and relapsing-remitting multiple sclerosis (RRMS) compared with healthy controls (HCs) matched for age, sex, and education level while considering the different characteristics of PPMS and RRMS and to compare the cognitive patterns of these types of multiple sclerosis.
METHODS: Forty-one patients with PPMS, 60 patients with RRMS, and 415 HCs were recruited in a cross-sectional study. Controls were divided into 20 groups according to age, sex, and education level. Participants were assessed with a large battery of neuropsychological (NP) tests that included a modified version of the Brief Repeatable Battery, the Stroop test, computerized tests from the Test of Attentional Performance battery, the numerical span test, and the Rey Complex Figure.
RESULTS: Patients with PPMS performed worse than their matched HCs on nearly all NP tests. Patients with RRMS performed worse than matched HCs on a computerized digit-symbol substitution task and the alertness test, reaction time for visual scanning, and Paced-Auditory Serial Addition Test-3 seconds. Patients with PPMS had worse NP scores and were more impaired in cognitive domains than patients with RRMS. After controlling for Expanded Disability Status Scale score, the results remained unchanged.
CONCLUSION: The patients with PPMS presented with a wide range of cognitive deficits in information processing speed, attention, working memory, executive function, and verbal episodic memory, whereas the impairments in patients with RRMS were limited to information processing speed and working memory compared with their matched HCs. Cognitive deficits were more severe in patients with PPMS than in patients with RRMS.

Entities:  

Mesh:

Year:  2013        PMID: 23516324     DOI: 10.1212/WNL.0b013e31828cf82f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  Altered neural mechanisms of cognitive control in patients with primary progressive multiple sclerosis: An effective connectivity study.

Authors:  Ekaterina Dobryakova; Maria Assunta Rocca; Paola Valsasina; John DeLuca; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2017-02-16       Impact factor: 5.038

2.  Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis.

Authors:  Eleonora Virgilio; Domizia Vecchio; Ilaria Crespi; Chiara Puricelli; Paolo Barbero; Giulia Galli; Roberto Cantello; Umberto Dianzani; Cristoforo Comi
Journal:  J Neurol       Date:  2022-01-28       Impact factor: 4.849

3.  The Rao's Brief Repeatable Battery in the study of cognition in different multiple sclerosis phenotypes: application of normative data in a Serbian population.

Authors:  Jelena Dackovic; Tatjana Pekmezovic; Sarlota Mesaros; Irena Dujmovic; Nebojsa Stojsavljevic; Vanja Martinovic; Jelena Drulovic
Journal:  Neurol Sci       Date:  2016-05-20       Impact factor: 3.307

4.  Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.

Authors:  Francesco Patti; Manuela De Stefano; Luigi Lavorgna; Silvia Messina; Clara Grazia Chisari; Domenico Ippolito; Roberta Lanzillo; Veria Vacchiano; Sabrina Realmuto; Paola Valentino; Gabriella Coniglio; Maria Buccafusca; Damiano Paolicelli; Alessandro D'Ambrosio; Patrizia Montella; Vincenzo Brescia Morra; Giovanni Savettieri; Bruno Alfano; Antonio Gallo; Isabella Simone; Rosa Viterbo; Mario Zappia; Simona Bonavita; Gioacchino Tedeschi
Journal:  PLoS One       Date:  2015-03-27       Impact factor: 3.240

Review 5.  Evaluation of Study and Patient Characteristics of Clinical Studies in Primary Progressive Multiple Sclerosis: A Systematic Review.

Authors:  T Ziemssen; S Rauer; C Stadelmann; T Henze; J Koehler; I-K Penner; M Lang; D Poehlau; M Baier-Ebert; H Schieb; S Meuth
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

6.  Altered likelihood of brain activation in attention and working memory networks in patients with multiple sclerosis: an ALE meta-analysis.

Authors:  K Kollndorfer; J Krajnik; R Woitek; J Freiherr; D Prayer; V Schöpf
Journal:  Neurosci Biobehav Rev       Date:  2013-09-19       Impact factor: 8.989

Review 7.  Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.

Authors:  Florian Castrop; Bernhard Haslinger; Bernhard Hemmer; Dorothea Buck
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-16       Impact factor: 2.570

8.  Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.

Authors:  Laura E Jonkman; Diana M Rosenthal; Maria Pia Sormani; Laura Miles; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

9.  Cognitive status in patients with multiple sclerosis in Lanzarote.

Authors:  María Yaiza Pérez-Martín; Pablo Eguia-Del Río; Montserrat González-Platas; Alejandro Jiménez-Sosa
Journal:  Neuropsychiatr Dis Treat       Date:  2016-06-30       Impact factor: 2.570

Review 10.  Social cognition in multiple sclerosis: A systematic review and meta-analysis.

Authors:  Jack Cotter; Joseph Firth; Christian Enzinger; Evangelos Kontopantelis; Alison R Yung; Rebecca Elliott; Richard J Drake
Journal:  Neurology       Date:  2016-09-21       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.